APA (7th ed.) Citation

Yaxley, W. J., McBean, R., Wong, D., Grimes, D., Vasey, P., Frydenberg, M., & Yaxley, J. W. (2021). Should Lutetium-prostate specific membrane antigen radioligand therapy for metastatic prostate cancer be used earlier in men with lymph node only metastatic prostate cancer? Korean Urological Association.

Chicago Style (17th ed.) Citation

Yaxley, William John, Rhiannon McBean, David Wong, David Grimes, Paul Vasey, Mark Frydenberg, and John William Yaxley. Should Lutetium-prostate Specific Membrane Antigen Radioligand Therapy for Metastatic Prostate Cancer Be Used Earlier in Men with Lymph Node Only Metastatic Prostate Cancer? Korean Urological Association, 2021.

MLA (8th ed.) Citation

Yaxley, William John, et al. Should Lutetium-prostate Specific Membrane Antigen Radioligand Therapy for Metastatic Prostate Cancer Be Used Earlier in Men with Lymph Node Only Metastatic Prostate Cancer? Korean Urological Association, 2021.